インスリンポンプ市場：ポンプタイプ、用途、エンドユーザー、地域別、2026年～2032年

インスリンポンプ市場の評価、2026年～2032年

ライフスタイルの変化と高齢化により、糖尿病、特に1型と2型の有病率が上昇しています。持続グルコースモニタリングシステムやスマート機能との統合など、インスリンポンプの設計と機能性における技術的進歩は、ユーザーエクスペリエンスと血糖値管理の有効性を高める。インスリンポンプのニーズは、2024年に255億6,000万米ドルを超え、2032年には695億4,000万米ドルに達します。

また、政府の支援策や有利な償還政策により、インスリンポンプはより身近なものとなっており、ヘルスケア専門家や患者の間でインスリン治療の利点に関する認識や教育が高まっていることも、普及率をさらに押し上げています。これらの要因により、さまざまな産業でインスリンポンプの使用が増加しており、2026年から2032年までのCAGRは約14.70%で成長すると予測されます。

インスリンポンプ市場定義/概要

インスリンポンプは、糖尿病患者に持続的にインスリンを投与するために設計された小型の携帯型医療機器であり、血糖値を効果的に管理するために正確かつ調節可能なインスリン投与を可能にします。これらの機器は主に1型糖尿病患者によって使用されているが、2型糖尿病患者にも採用されるようになってきています。インスリンポンプは、基礎およびボーラス・インスリン投与、持続グルコース・モニタリング・システムとの統合、ユーザーの利便性と糖尿病管理のコントロールを高めるプログラム可能な機能など、さまざまなアプリケーションを提供します。将来を展望すると、インスリンポンプ市場は、クローズドループシステム（人工膵臓技術）の開発などの技術的進歩、糖尿病管理に対する意識の高まり、世界の糖尿病有病率の上昇に牽引され、大きな成長が見込まれています。

糖尿病有病率の上昇はインスリンポンプ市場を促進するか？

糖尿病有病率の上昇は、インスリンポンプ市場を大きく促進しています。世界人口の増加と高齢化が進むにつれ、糖尿病、特に2型糖尿病の罹患率は上昇傾向にあります。国際糖尿病連合（IDF）によると、2021年には世界で約5億3,700万人の成人が糖尿病を患っており、この数字は2045年には7億8,300万人に達すると予測されています。米国では、疾病対策予防センター（CDC）の報告によると、2022年には約3,730万人が糖尿病を患っており、人口の約11.3％を占めています。このような糖尿病患者数の増加は、インスリンポンプを含む効果的な管理ソリューションに対する需要の高まりと直結しています。

先進的な糖尿病管理ツールの必要性は、血糖コントロールの改善やインスリン投与の柔軟性向上など、インスリンポンプが提供する利点に対する認識が高まっていることによって、さらに強調されています。ヘルスケア・プロバイダーが、患者の病状を効果的に管理するための革新的な治療法を提唱する中、インスリンポンプは糖尿病治療の不可欠な一部となりつつあります。CDCはまた、糖尿病を効果的に管理することが合併症を減らし、生活の質を高め、ヘルスケアコストを削減することを強調しています。

高い開発コストはインスリンポンプ市場の成長を妨げるか？

開発コストの高さは、確かにインスリンポンプ市場の成長を妨げる重要な要因です。先進的なインスリンポンプ技術の開発には、安全性と有効性を確保するための研究開発、規制遵守、臨床試験への多額の投資が必要となります。こうしたコストは、中小企業の市場参入を阻み、競争を制限する可能性があります。その結果、革新的なソリューションが減少し、技術の進歩が遅れる可能性があります。さらに、インスリンポンプの高価格は小売価格の上昇につながることが多く、特に保険適用が限られている地域や自己負担額が大きい地域では、患者のアクセスが制限される可能性があります。

さらに、高い開発費による経済的負担は、メーカーの価格戦略に影響を与える可能性があります。企業はこれらのコストを消費者に転嫁せざるを得なくなり、インスリンポンプが購入しにくくなり、潜在的なユーザーの間での普及が制限される可能性があります。このことは、2型糖尿病においては特に有害であり、患者はすぐに健康上の利益が得られない高価な機器への投資に消極的になる可能性があります。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 インスリンポンプ市場：ポンプタイプ別

• 従来のインスリンポンプ
• パッチポンプ
• チューブレスポンプ

第5章 インスリンポンプ市場：エンドユーザー別

• 病院
• 在宅医療
• ラボ

第6章 インスリンポンプ市場：用途別

• 1型糖尿病
• 2型糖尿病
• 妊娠糖尿病

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Medtronic plc
• F. Hoffmann-La Roche Ltd
• Insulet Corporation
• Tandem Diabetes Care, Inc.
• SOOIL Development Co., Ltd.
• Becton, Dickinson and Company
• Cellnovo Group
• Ypsomed Holding AG
• Medtrum, Inc.
• CanSino Biologics Inc.

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Insulin Pumps Market Valuation - 2026-2032

The rising prevalence of diabetes, particularly Type 1 and Type 2, driven by lifestyle changes and an aging population. Technological advancements in insulin pump design and functionality, such as integration with continuous glucose monitoring systems and smart features, enhance user experience and effectiveness in managing blood glucose levels. The need for insulin pumps is surpassing USD 25.56 Billion in 2024 and reaching USD 69.54 Billion by 2032.

Additionally, supportive government initiatives and favorable reimbursement policies are making insulin pumps more accessible, while increased awareness and education among healthcare professionals and patients about the benefits of insulin therapy further boost adoption rates. These factors contribute to the increasing use of insulin pumps in a variety of industries is expected to grow at a CAGR of 14.70% about from 2026 to 2032.

Insulin Pumps Market: Definition/ Overview

Insulin pumps are small, portable medical devices designed to deliver continuous insulin to individuals with diabetes, allowing for precise and adjustable insulin administration to manage blood glucose levels effectively. These devices are primarily used by people with Type 1 Diabetes, but they are increasingly being adopted by those with Type 2 Diabetes as well. Insulin pumps provide various applications, including basal and bolus insulin delivery, integration with continuous glucose monitoring systems, and programmable features that enhance user convenience and control over their diabetes management. Looking to the future, the Insulin Pumps Market is poised for significant growth, driven by technological advancements such as the development of closed-loop systems (artificial pancreas technology), increasing awareness of diabetes management, and the rising prevalence of diabetes globally.

Will Rising Prevalence of Diabetes is Propelling the Insulin Pumps Market?

The rising prevalence of diabetes is significantly propelling the Insulin Pumps Market. As the global population continues to grow and age, the incidence of diabetes, particularly Type 2 Diabetes, is on the rise. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide were living with diabetes in 2021, a figure projected to reach 783 million by 2045. In the United States, the Centers for Disease Control and Prevention (CDC) reported that around 37.3 million people had diabetes in 2022, accounting for about 11.3% of the population. This increasing number of diabetes cases directly correlates with a heightened demand for effective management solutions, including insulin pumps.

The need for advanced diabetes management tools is further underscored by the growing recognition of the benefits that insulin pumps offer, such as improved glycemic control and greater flexibility in insulin delivery. As healthcare providers advocate for innovative treatment options to help patients manage their condition effectively, insulin pumps are becoming an integral part of diabetes care. The CDC also emphasizes that managing diabetes effectively can reduce complications, enhance the quality of life, and lower healthcare costs.

Will High Development Cost Hamper the Growth of the Insulin Pumps Market?

High development costs are indeed a significant factor that may hamper the growth of the Insulin Pumps Market. Developing advanced insulin pump technology requires substantial investments in research and development, regulatory compliance, and clinical trials to ensure safety and efficacy. These costs can deter smaller companies from entering the market and limit competition, potentially resulting in fewer innovative solutions and slower advancements in technology. Furthermore, the high price of insulin pumps often translates to elevated retail prices, which can restrict access for patients, particularly in regions with limited insurance coverage or high out-of-pocket expenses.

Additionally, the financial burden of high development costs can impact the pricing strategies of manufacturers. Companies may be compelled to pass on these costs to consumers, making insulin pumps less affordable and limiting their adoption among potential users. This can be particularly detrimental in the context of Type 2 Diabetes, where patients may be reluctant to invest in expensive devices without immediate health benefits.

Category-Wise Acumens

Will Consistent Insulin Delivery in Type 1 Diabetes Boost the Insulin Pumps Market?

Consistent insulin delivery in Type 1 Diabetes is expected to significantly boost the Insulin Pumps Market. Individuals with Type 1 Diabetes require precise and regular insulin administration to maintain optimal blood glucose levels and avoid complications associated with the disease. Insulin pumps provide a continuous delivery system, allowing users to adjust their insulin intake based on their activity levels, dietary intake, and blood sugar readings. This technology offers a more flexible and user-friendly approach compared to traditional insulin injections, leading to improved adherence to treatment regimens and better overall health outcomes for patients.

Furthermore, advancements in insulin pump technology, such as integration with continuous glucose monitoring systems and smart features that facilitate automated insulin delivery, are enhancing their appeal to Type 1 Diabetes patients.

The Type 2 Diabetes segment is the fastest growth, driven by rising obesity rates, lifestyle changes, and increasing awareness of diabetes management options.

Will Increasing Consumer Demand for Traditional Insulin Pumps Fuel the Insulin Pumps Market?

The increasing consumer demand for traditional insulin pumps is expected to significantly fuel the Insulin Pumps Market. Traditional insulin pumps are known for their reliability and advanced features, such as programmable insulin delivery rates and continuous glucose monitoring capabilities. As more patients seek effective diabetes management solutions, these devices are becoming increasingly popular among individuals requiring intensive insulin therapy. The integration of smart technology into traditional pumps also enhances their appeal, offering patients greater control over their diabetes management.

Moreover, the growing awareness of diabetes management among healthcare providers and patients alike is contributing to the rising demand for traditional insulin pumps. Educational initiatives and government programs promoting advanced diabetes care are further driving this trend.

The fastest-growing segment is the tubeless pumps, driven by their convenience, portability, and ease of use, which enhance patient adherence to diabetes management.

Country/Region-wise

Will Advanced Technological Infrastructure in North America Drive the Expansion of The Insulin Pumps Market?

Advanced technological infrastructure in North America is expected to drive the expansion of the Insulin Pumps Market. North America, particularly the United States, has a highly developed healthcare system, characterized by the rapid adoption of innovative medical technologies. Insulin pumps, which offer precise insulin delivery, benefit from this environment due to the availability of advanced manufacturing facilities and robust research and development in medical devices. The United States government has also promoted healthcare initiatives that support the use of advanced diabetes management technologies, contributing to the growing demand for insulin pumps.

Statistically, the prevalence of diabetes in North America further underscores the demand for insulin pumps. According to the U.S. Centers for Disease Control and Prevention (CDC), around 11.3% of the U.S. population, or approximately 37.3 million people, were living with diabetes as of 2022. This increasing diabetic population fuels the need for insulin pumps as an effective management tool. Additionally, government initiatives such as Medicare coverage for insulin pump users are likely to boost the market, with the Centers for Medicare & Medicaid Services (CMS) reporting a steady rise in reimbursements for diabetes-related technologies.

Will Increasing Adoption of Digital Technologies in Asia Pacific Propel the Insulin Pumps Market?

The increasing adoption of digital technologies in the Asia Pacific region is expected to significantly propel the Insulin Pumps Market. With growing cases of diabetes and the rise of digital healthcare, the demand for advanced insulin delivery systems has surged. Insulin pumps, which offer more precise control over blood glucose levels, have seen higher adoption due to improved digital interfaces and compatibility with smartphones. Governments across Asia Pacific are also pushing for better diabetes management through digital tools. For example, in India, the government has launched initiatives like the "Ayushman Bharat Digital Mission" to boost digital health infrastructure, increasing access to insulin pumps and other diabetes management devices.

Moreover, the region's governments are taking steps to combat the diabetes epidemic. According to the International Diabetes Federation (IDF), around 88 million adults in Southeast Asia were living with diabetes in 2021, and the numbers are expected to grow. In China, government health reports indicate that nearly 10% of the adult population suffers from diabetes, making it a focal market for insulin pump manufacturers. With such a high prevalence of diabetes and favorable government support, the insulin pump market in Asia Pacific is projected to grow robustly, driven by the rise in healthcare digitalization.

Competitive Landscape

The competitive landscape of the Insulin Pumps Market is characterized by a mix of established players and emerging startups, each focusing on innovative features such as real-time tracking, integration with IoT devices, and user-friendly interfaces. Companies are increasingly investing in research and development to enhance product offerings and improve customer service, creating a dynamic and rapidly evolving market environment.

Some of the prominent players operating in the Insulin Pumps Market include Medtronic plc, Hoffmann-La Roche Ltd, Insulet Corporation, Tandem Diabetes Care, Inc., SOOIL Development Co., Ltd., Becton, Dickinson and Company, Cellnovo Group, Ypsomed Holding AG, Medtrum, Inc., CanSino Biologics Inc.

Latest Developments

In August 2023 Medtronic announced the launch of its next-generation MiniMed 780G insulin pump system in Europe, featuring an advanced algorithm designed to automatically adjust insulin delivery every five minutes. This system also integrates with continuous glucose monitoring (CGM) and provides better glycemic control, particularly for patients with type 1 diabetes.

In July 2023 Roche launched its updated Accu-Chek Insight insulin pump system in select European countries. The new model offers enhanced precision in insulin dosing and integrates with digital health platforms, allowing patients and healthcare providers to monitor glucose levels and make real-time adjustments remotely.

In June 2023 Insulet received U.S. Food and Drug Administration (FDA) approval for its Omnipod 5 Automated Insulin Delivery System. This tubeless insulin pump integrates with Dexcom G6 CGM and allows users to control the system via a mobile app. The approval marked a significant step in expanding the options for people living with diabetes.

Insulin Pumps Market, By Category

• Type of Pump
• Traditional Insulin Pumps
• Patch Pumps
• Tubeless Pumps
• Application
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• End User
• Hospitals
• Homecare
• Labs
• Geography:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Insulin Pumps Market, By Type of Pump

• Traditional Insulin Pumps
• Patch Pumps
• Tubeless Pumps

5. Insulin Pumps Market, By End User

• Hospitals
• Homecare
• Labs

6. Insulin Pumps Market, By Application

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic plc
• F. Hoffmann-La Roche Ltd
• Insulet Corporation
• Tandem Diabetes Care, Inc.
• SOOIL Development Co., Ltd.
• Becton, Dickinson and Company
• Cellnovo Group
• Ypsomed Holding AG
• Medtrum, Inc.
• CanSino Biologics Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References